| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 113.457 | 77 |
| GSM780708 | Untreated after 4 days (C2_1) | 87.231 | 73 |
| GSM780709 | Untreated after 4 days (C3_1) | 116.263 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 116.955 | 77 |
| GSM780720 | Untreated after 4 days (C2_2) | 92.0835 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 126.812 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 66.4357 | 68 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 80.5104 | 72 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 81.9343 | 72 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 85.1623 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 91.4003 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 93.309 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 155.636 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 79.3577 | 72 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 109.57 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 177.163 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 78.8725 | 71 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 122.357 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 160.611 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 105.065 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 88.4373 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 141.172 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 99.9391 | 75 |